Advertisement
Screener

Beam Therapeutics Inc. (BEAM) Pre-Tax Margin

Beam Therapeutics Inc. (BEAM) Pre-Tax Margin

  • 2025-12-31: Pre-Tax Margin 214.09%.
  • 2025-09-30: Pre-Tax Margin -1162.38%.
  • 2025-06-30: Pre-Tax Margin -1208.26%.
  • 2024-12-31: Pre-Tax Margin -300.51%.

Complete source-backed pre-tax margin history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2025-12-31214.09%
2025-09-30-1162.38%
2025-06-30-1208.26%
2024-12-31-300.51%
2024-09-30-677.47%
2024-06-30-773.12%
2023-12-3145.59%
2023-09-30-558.88%
2023-06-30-411.49%
2022-12-31-186.40%
2022-09-30-516.90%
2021-12-31-126.71%
2021-09-30-3685.19%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-57.24%
2024-12-31-593.06%
2023-12-31-34.73%
2022-12-31-427.08%
2021-12-31-714.91%
2020-12-31-810800.00%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
NOVAVAX INC (NVAX)United States$1.748B-6.26